Physician Assistant · Miami, FL
NPI
1437714086
Since 2019
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
7400 SW 87th Ave Ste 100
Miami, FL, 33173
Phone (786) 204-4201
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
882 services
Medicare patients, 2024
185
Average age 73
Drug cost, 2024
$1.6M
2,096 prescriptions
Company payments, 2025
$1,205
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Emilia R Gucciardo was code 99214 (office e&m - established), 273 times for 178 patients. In total Emilia R Gucciardo billed 882 services in 10 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 273 | 178 | $91.22 | $25K |
| 36415 Venipuncture Blood Collection | Office | 18 | 16 | $5.88 | $106 |
| 99213 Office E&M - Established | Office | 15 | 13 | $64.37 | $966 |
By year: 2022 $16K for 440 services; 2023 $12K for 411 services; 2024 $31K for 882 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 18 | 16 | $5.88 | $106 |
Medicare prescription drug claims, 2024
In 2024, the drug Emilia R Gucciardo prescribed most often to Medicare patients was Repatha Sureclick (Evolocumab), with 925 prescriptions and refills. In total Emilia R Gucciardo wrote 2,096 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Repatha Sureclick Evolocumab | 925 | 1,814 | 282 | $1.0M |
| Praluent Pen Alirocumab | 185 | 379 | 54 | $187K |
| Rosuvastatin Calcium Generic | 150 | 434 | 71 | $1,485 |
| Ozempic Semaglutide | 126 | 154 | 35 | $130K |
| Ezetimibe Generic | 83 | 222 | 42 | $1,336 |
| Wegovy Semaglutide | 73 | 80 | 20 | $108K |
| Atorvastatin Calcium Generic | 64 | 166 | 34 | $340 |
| Nexlizet Bempedoic Acid/Ezetimibe | 55 | 99 | 21 | $39K |
| Amlodipine Besylate Generic | 51 | 128 | 21 | $303 |
| Vascepa Icosapent Ethyl | 50 | 117 | 21 | $41K |
| Mounjaro Tirzepatide | 31 | 31 | Under 11 | $32K |
| Losartan Potassium Generic | 28 | 82 | 16 | $485 |
| Icosapent Ethyl Generic | 22 | 36 | Under 11 | $8,064 |
| Hydralazine Hcl Generic | 20 | 52 | Under 11 | $147 |
| Carvedilol Generic | 20 | 58 | 11 | $123 |
Brand drugs: 1,480 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Emilia R Gucciardo $1,205 ($1,205 in general payments such as food, travel and fees) from 11 companies. The largest payer was Novo Nordisk Inc with $478.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 30 | $478 |
| Amgen Inc. AMGN | 9 | $219 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $104 |
| Ionis Pharmaceuticals, Inc. IONS | 4 | $103 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $80.61 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $73.43 |
| Abiomed JNJ | 2 | $45.4 |
| Lilly USA, LLC LLY | 2 | $39.82 |
| Cleerly, Inc. | 1 | $25 |
| Pfizer Inc. PFE | 1 | $23.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.